CRM
60
-7
KEY
43
-3
ZBH
65
3
INTC
41
4
ESS
62
-3
SNA
70
-5
THC
60
-5
WMB
68
2
SBUX
37
-2
GILD
47
-8
CNX
73
-3
KO
38
-3
GLW
45
-3
HRL
35
-3
EIX
70
3
PVH
60
-4
TGNA
50
-6
AME
74
-4
ILMN
32
-9
PLD
45
-5
CRM
60
-7
KEY
43
-3
ZBH
65
3
INTC
41
4
ESS
62
-3
SNA
70
-5
THC
60
-5
WMB
68
2
SBUX
37
-2
GILD
47
-8
CNX
73
-3
KO
38
-3
GLW
45
-3
HRL
35
-3
EIX
70
3
PVH
60
-4
TGNA
50
-6
AME
74
-4
ILMN
32
-9
PLD
45
-5
Financhill
Back

Assembly Biosciences 10K Form

Sell
30

ASMB
Assembly Biosciences

Last Price:
16.14
Seasonality Move:
9.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-17.12M
Price / Cash Flow: 3.49
Annual Sales: $5.47
Price / Book: 2.95

Profitability

EPS (TTM): -8.62000
Net Income (TTM): $-45.61M
Gross Margin: $0
Return on Equity: -111.22%
Return on Assets: -46.52%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.74
Quick Ratio: 2.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
30
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?